Showing posts with label Malignant. Show all posts
Showing posts with label Malignant. Show all posts

Monday, April 11, 2011

Percutaneous Hepatic Perfusion to Treat Malignant Melanoma

In this two-minute video, Dr. H. Richard Alexander, professor of surgery at the University of Maryland School of Medicine and surgical oncologist at the University of Maryland Greenebaum Cancer Center discusses a recent nation-wide clinical trial that tested a new procedure, known as percutaneous hepatic perfusion, in the treatment of malignant melanoma that has spread to the liver. Dr. Alexander talks about the preliminary results of this clinical trial and the implications these results could have on the future treatment of this disease. Related Links: University of Maryland Greenebaum Cancer Center www.umgcc.org Surgical Oncology Program www.umgcc.org Gastrointestinal Oncology Program www.umgcc.org Video: Malignant Peritoneal Mesothelioma www.umm.edu Patient Education www.umgcc.org



http://www.youtube.com/watch?v=-e-LeaLEMKM&hl=en

Monday, January 3, 2011

Malignant Peritoneal Mesothelioma

Malignant Peritoneal Mesothelioma is neoplasm arising from the serosal lining of the peritoneal and pericardial cavities. Primary tumors arising from the peritoneal mesothelioma are extremely rare. The accurate diagnosis of the diffuse peritoneal mesothelioma is important because it almost invariably has a fatal outcome. In many cases, malignant peritoneal mesothelioma is not diagnosed until after surgery or autopsy. The distinction of the malignant peritoneal mesothelioma from tumors metastatic to the serosal membranes can often be made based on the results of histochemical studies.

The most common symptoms of malignant peritoneal mesothelioma are difficulty in breathing, chest pain, or both. Other symptoms include weight loss, fever, night sweats, cough, and a general feeling of not being well, although these symptoms are not as common.

The standard treatment for the malignant peritoneal mesothelioma is not curative. Aggressive treatment will enable some patients to experience long-term survival, but it is still unclear whether overall survival rates would be significantly changed by different treatments or combinations of treatments. There are different treatments available for the malignant peritoneal mesothelioma, depending upon the state of its diagnosis. For stage one, that is localized malignant peritoneal Mesothelioma, standard treatments are malignant peritoneal mesothelioma, intracavitary mesothelioma, intracavitary chemotherapy following resection.

For stages 2 to 4, that is advanced malignant peritoneal mesothelioma, treatments available are symptomatic treatment to include drainage of effusions, chest tube pleurodesis, or thoracoscopic pleurodesis, palliative surgical resection in selected patients, palliative radiation therapy, single-agent chemotherapy, and multimodality clinical trials.

To date, there are no treatment approaches that have been shown to improve survival or control symptoms for a prolonged period of time. But with the advancement in the field of technology and medicine, there is hope that some day, doctors will be able to defeat the tumor and come out with some life-saving treatment against this dreadful tumor.




Mesotherapy [http://www.e-MesoTherapy.com] provides detailed information about mesotherapy, cost of mesotherapy, mesotherapy before and after, mesotherapy injections and more. Mesotherapy is the sister site of Mesothelioma Doctors Info.

Sunday, January 2, 2011

High Incidence Of Malignant Pleural Mesothelioma In Australia

Australia has the highest per capita rate of mesothelioma cases. The worst, experts say, is yet to come, Most of the mesothelioma cases in Australia are of the malignant pleural mesothelioma type. Most of the detected cases have contracted the disease due to exposure to asbestos. When the asbestos fibers or asbestos dust is inhaled through the nose, it travels down the respiratory system. Then it settles down in the lungs. The lungs have a lining called as the mesothelium lining. When this lining comes in touch with the asbestos fibers, it starts behaving in a funny manner.

It starts dividing rapidly and it also starts having longer life spans. This causes tumors in the lungs and this condition is called pleural mesothelioma. This may be cancerous (malignant pleural mesothelioma) or non-cancerous (benign pleural mesothelioma). Australia has a very high number of malignant pleural mesothelioma cases. This is a very terrible condition and has no known cure. Since the symptoms of this disease like fever, cough, chest pain, etc. are often confused with other diseases like pneumonia; it is quite difficult to correctly diagnose this disease.

Mostly it is diagnosed only in the last stages of the cancer. The patient lives for hardly a year after the diagnosis. Also, the latency period of this disease is very long. Latency period is the period between exposure to asbestos fibers and the onset of this disease. Because of the long latency period of nearly 20 to 30 years, many times this disease is not spoken as connected to asbestos. Australia has about 16 cases per million populations of adults affected with mesothelioma every year. Also, the number of mesothelioma cases in men is much higher than women. Around 600 cases of mesothelioma are recorded every year in Australia. It is expected that in the next 10-15 years, some 13000 more mesothelioma cases will be recorded.

There is a high-risk group in Australia. The following people of Australia seem to be getting mesothelioma more as compared to the remaining population:

o Town Residents

o Builders and building laborers

o Workers of shipbuilding and dockyard

o Railway workers

o Asbestos factory workers

o Power station employees.

Though Australia has such a huge incidence of mesothelioma deaths, Australia is the world's pioneer in undertaking lot of medical research in mesothelioma. It has found a new method of treatment that promises to reduce the mortality rate. Since, there is no cure for this disease, it is better if it detected earlier. The normal methods of treatment like chemotherapy and surgery do not work in the last stages of cancer; so it is better if the disease is detected as early as possible. The Australian researchers have invented a new Screening test that can help detect mesothelioma of the malignant pleural type. This can be used in the high-risk group to find out early evidences of the malignant pleural mesothelioma. The earlier the disease is detected, the more better the chances of survival of the patient. The Australian researchers are undertaking more and more research in the medical field of mesothelioma. Australia is a real pioneer in mesothelioma research. It is a leader and example for all the other countries. Though Australia has done So much to advance mesothelioma research, still the future of Australia is bleak.

It is expected what the number of mesothelioma deaths in Australia will continue to skyrocket till the year 2020. After this, it is expected that the mesothelioma deaths will steadily decline before finally stopping. This is mainly because of the long latency period of mesothelioma. So, even after all types of asbestos are completely banned, the effects of asbestos exposure can be felt till some 20 to 30 years later. The one advantage of all the research is that the chances of survival have increased for mesothelioma patients.

Also, the life span of the patient after the detection of the disease has increased. Previously, the patient had hardly a year left to live. However, now, due to early diagnosis, this has substantially increased. Australia should continue to undertake more research on mesothelioma for the global good. It should try to advance medical science to make new innovations in the treatment of mesothelioma. All the other countries should actively support and help Australian efforts. Australia should also make available the fruits of its efforts for the entire wide world.




The writer is a research expert at a medical research firm. Webmaster: http://www.rarehope.com

Friday, December 24, 2010

Malignant Mesothelioma and Benign Mesothelioma - How Are They Different?

Most of your body's internal organs are covered by a membrane called the mesothelium. When a person gets a type of malignant or benign cancer called mesothelioma it affects the mesothelium.

The pleura is the lining around your lungs. Most mesothelioma cases start in the pleura or the peritoneum, which is the lining that surrounds your abdomen.

What Causes Mesothelioma?

Wherever it begins, the disease was almost always a result of being exposed to asbestos.

Asbestos is a silicate that has been mined and used for centuries because of its many useful properties which include thermal insulation, thermal stability, and chemical stability. Many of the people who have developed malignant mesothelioma have had jobs where they were exposed to asbestos fibers and either inhaled or swallowed the particles.

Malignant Mesothelioma Survival Rates

Mesothelioma survival rates reflect the percentage of people who have the disease and survive for a specific amount of time. Survival rates often reflect a five year time span.

Generally, the survival rate for mesothelioma depends on the following:

1. The patient's health and age

2. The stage of mesothelioma

3. The tumor's size

4. Whether or not the tumor can be removed

Since many variables are involved there are not absolutes. For example, if a patient is diagnosed with stage 1 mesothelioma and is generally in good health then he or she might be a candidate for mesothelioma treatment or surgery. If there is a good response to the treatments then there could be significant improvements for the chance of survival.

With that being said, here are average survival rates for mesothelioma sufferers:

- Approximately 40% survive the first year

- Approximately 20% survive the second year

- Approximately 12% survive the third year

- Approximately 10% survive the fourth year

- Less than 10% survive the fifth year

Since conditions do vary from one person to the next it is recommended that patients consult with their doctors.

What is Benign Mesothelioma?

Approximately 10% of all mesothelioma cases are benign. Because it isn't cancerous, treatment is much easier and it can be removed.

The symptoms are very similar to those of cancerous mesothelioma. However benign tumors don't invade nearby organs and tissues. They don't spread to other parts of a person's body.

Nonetheless, if a benign tumor grows large enough it can induce seizures or comas.

Once a person is diagnosed with benign mesothelioma then treatment and/or surgery will probably be scheduled. Most patients completely recover. Their pain usually diminishes and they most likely will find it easier to breathe.

Research indicates that 90% of benign mesothelioma patients have not had a repeated occurrence of a tumor growth.




Next, if you suffer from mesothelioma and would like to schedule free consultation with a firm that specializes in mesothelioma cases, go to => http://www.mesorc.com.

Wendy Moyer on behalf of Sokolove Law.

Sunday, November 21, 2010

Malignant Pleural Mesothelioma Treatment - Dr. Raja Flores

www.curemeso.org Understand mesothelioma treatment options through surgery from the International Symposium on Malignant Mesothelioma. Presentation by Dr. Raja Flores on pleural mesothelioma surgical options. Learn more about mesothelioma treatment and symptoms by visiting www.curemeso.org



http://www.youtube.com/watch?v=pemZkUwJXcU&hl=en